Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

People with alopecia areata have higher insulin resistance.

Minoxidil helps hair regrowth in alopecia, but more research needed.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.